Detection of infectious human immunodeficiency virus type 1 in female genital secretions by a short-term culture method

Journal of Clinical Microbiology

Volumn 41, Issue 9, 2003, Pages 4081-4088

  Cummins Jr , James E ^a   Villanueva, Julie M ^c   Evans Strickfaden, Tammy ^a   Sesay, Shekou M ^a   Abner, Sheila R ^a   Bush, Timothy J ^b   Green, Timothy A ^a   Lennox, Jeffrey L ^c   Wright, Thomas ^d   Folks, Thomas M ^a   Hart, Clyde E ^a   Dezzutti, Charlene S ^a  

^a NATL CENTER FOR INFECTIOUS DISEASES   (United States)

^b CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^c EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d Columbia University ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ANALYTIC METHOD; ARTICLE; ASSAY; CLINICAL ARTICLE; COCULTURE; DISEASE ASSOCIATION; FEMALE; GENITAL TRACT INFECTION; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; LAVAGE; LYMPHOCYTE COUNT; MONONUCLEAR CELL; MULTINUCLEAR ACTIVATION GALACTOSIDASE INDICATOR ASSAY; PH; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SEXUAL TRANSMISSION; VAGINA SECRETION; VIRUS CULTURE; VIRUS DETECTION; VIRUS LOAD;

ADOLESCENT; ADULT; BETA-GALACTOSIDASE; CATHEPSIN D; CD4 LYMPHOCYTE COUNT; COCULTURE TECHNIQUES; COLORIMETRY; CYTOKINES; FEMALE; GENITAL DISEASES, FEMALE; HIV-1; HUMANS; HYDROGEN-ION CONCENTRATION; MIDDLE AGED; VAGINA;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1; RNA VIRUSES;

EID: 0042421545     PISSN: 00951137     EISSN: None     Source Type: Journal    
DOI: 10.1128/JCM.41.9.4081-4088.2003     Document Type: Article

References (47)

1. Alfsen, A., P. Iniguez, E. Bouguyon, and M. Bomsel. 2001. Secretory lgA specific for a conserved epitope on gp41 envelope glycoprotein inhibits epithelial transcytosis of HIV-1. J Immunol. 166:6257-6265.
2. Al-Harthi, L., G. T. Spear, F. B. Hashemi, A. Landay, B. E. Sha, and K. A. Roebuck. 1998. A human immunodeficiency virus (HIV)-inducing factor from the female genital tract activates HIV-1 gene expression through the KB enhancer. J. Infect. Dis. 178:1343-1351.
3. Anderson, D. J., J. A. Politch, L. D. Tucker, R. Fichorova, F. Haimovici, R. E. Tuomala, and K. H. Mayer. 1998. Quantitation of mediators of inflammation and immunity in genital tract secretions and their relevance to HIV type 1 transmission. AIDS Res. Hum. Retrovir. 14:S43-S49.
4. Belec, L., R. Gherardi, C. Payan, T. Prazuck, J. E. Malkin, C. Tevi-Benissan, and J. Pillot. 1995. Proinflammatory cytokine expression in cervicovaginal secretions of normal and HIV-infected women. Cytokine 7:568-574.
5. Blaak, H., L. J. Ran, R. Rientsma, and H. Schuitemaker. 2000. Susceptibility of in vitro stimulated PBMC to infection with NSI HIV-1 is associated with levels of CCR5 expression and β-chemokine production. Virology 267:237-246.
6. Bomsel, M., M. Heyman, H. Hocini, S. Lagaye, L. Belec, C. Dupont, and C. Desgranges. 1998. Intracellular neutralization of HIV transcytosis across tight epithelial barriers by anti-HIV envelope protein dIgA or IgM, Immunity 9:277-287.
7. Cummins, J. E., Jr., and C. S. Dezzutti. 2000. Sexual HIV-1 transmission and mucosal defense mechanisms. AIDS Rev. 2:144-154.
8. Cu Uvin, S., and A. M. Caliendo. 1997. Cervicovaginal human immunodeficiency virus secretion and plasma viral load in human immunodeficiency virus-seropositive women. Obstet. Gynecol. 90:739-743.
9. Davies, A. 1978. A preliminary investigation using p-nitrophenyl phosphate to quantitate acid phosphatase on swabs examined in cases of sexual assault. Med. Sci. Law 18:174-178.
10. Demeter, L. M., R. J. Bosch, R. W. Coombs, S. Fiscus, J. Bremer, V. A. Johnson, A. Erice, J. B. Jackson, S. A. Spector, K. M. Squires, M. A. Fischl, M. D. Hughes, and S. M. Hammer. 2002. Detection of replication-competent human immunodeficiency virus type 1 (HIV-1) in cultures from patients with levels of HIV-1 RNA in plasma suppressed to less than 500 or 50 copies per milliliter. J. Clin. Microbiol. 40:2089-2094.
11. Dianzani, F., G. Antonelli, E. Riva, O. Turriziani, L. Antonelli, S. Tyring, D. A. Carrasco, H. Lee, D. Nguyen, J. Pan, J. Poast, M. Cloyd, and S. Baron. 2002. Is human immunodeficiency virus RNA load composed of neutralized immune complexes? J. Infect. Dis. 185:1051-1054.
12. El Messaoudi, K., L. Thiry, N. Van Tieghem, C. Liesnard, Y. Englert, N. Moguilevsky, and A. Bollen. 1999. HIV-1 infectivity and host range modification by cathepsin D present in human vaginal secretions. AIDS 13:333-339.
13. Goulston, C., W. McFarland, and D. Katzenstein. 1996. Human immunodeficiency virus type 1 RNA in the female genital tract. J. Infect. Dis. 177:1100-1103.
14. Gray, R. H., M. J. Wawer, R. Brookmeyer, N. K. Sewankambo, D. Serwadda, F. Wabwire-Mangen, T. Lutalo, X. Li, T. vanCott, and T. C. Quinn. 2001. Probability of HIV-1 transmission per coital act in monogamous, heterosexual, HIV-1-discordant couples in Rakai, Uganda. Lancet 357:1149-1153.
15. Gray, R. H., N. Kiwanuka, T. C. Quinn, N. K. Sewankambo, D. Serwadda, F. W. Mangen, T. Lutalo, F. Nalugoda, R. Kelly, M. Meehan, M. Z. Chen, C. Li, and M. J. Wawer. 2000. Male circumcision and HIV acquisition and transmission: cohort studies in Rakai, Uganda. AIDS 14:2371-2381.
16. Guenthner, P. C., and C. E. Hart. 1998. Quantitative, competitive, PCR assay for HIV-1 using a microplate-based detection system. BioTechniques 24:810-816.
17. Hart, C. E., J. L. Lennox, M. Pratt-Palmore, T. C. Wright, R. F. Schinazi, T. Evans-Strickfaden, T. J. Bush, C. Schnell, L. J. Conley, K. A. Clancy, and T. V. Ellerbrock. 1999. Correlation of human immunodeficiency virus type 1 RNA levels in blood and the female genital tract. J. Infect. Dis. 179:871-882.
18. Henin, Y., L. Mandelbrot, R. Henrion, R. Pradinaud, J. P. Coulaud, and L. Montagnier. 1993. Virus excretion in the cervicovaginal secretions of pregnant and nonpregnant HIV-infected women. J. Acquir. Immune Defic. Syndr. 6:72-75.
19. Hocini, H., L. Belec, S. Iscaki, B. Garin, J. Pillot, P. Becquart, and M. Bomsel. 1997. High-level ability of secretory IgA to block HIV type 1 transcytosis: contrasting secretory IgA and IgG responses to glycoprotein 160. AIDS Res. Hum. Retrovir. 13:1179-1185.
20. Iversen, A. K., A. R. Larsen, T. Jensen, L. Fugger, U. Balslev, S. Wahl, J. Gerstoft, J. I. Mullins, and P. Skinhoj. 1998. Distinct determinants of human immunodeficiency virus type 1 RNA and DNA loads in vaginal and cervical secretions. J. Infect. Dis. 177:1214-1220.
21. Kimpton, J., and M. Emerman. 1992. Detection of replication-competent and pseudotyped human immunodeficiency virus with a sensitive cell line on the basis of activation of an integrated β-galactosidase gene. J. Virol. 66:2232-2239.
22. Kreiss, J., D. M. Willerford, M. Hensel, W. Emonyi, F. Plummer, J. Ndinya-Achola, P. L. Roberts, J. Hoskyn, S. Hillier, and N. Kiviat. 1994. Association between cervical inflammation and cervical shedding of human immunodeficiency virus DNA. J. Infect. Dis. 170:1597-1601.
23. Kreiss, J. K., R. Coombs, F. Plummer, K. K. Holmes, B. Nikora, W. Cameron, E. Ngugi, J. O. Ndinya Achola, and L. Corey. 1989. Isolation of human immunodeficiency virus from genital ulcers in Nairobi prostitutes. J. Infect. Dis. 160:380-384.
24. Lawn, S. D., S. Subbarao, T. C. Wright, Jr., T. Evans-Strickfaden, T. V. Ellerbrock, J. L. Lennox, S. T. Butera, and C. E. Hart. 2000. Correlation between human immunodeficiency virus type I RNA levels in the female genital tract and immune activation associated with ulceration of the cervix. J. Infect. Dis. 181:1950-1956.
25. Martin, H. L., B. A. Richardson, P. M. Nyange, L. Lavreys, S. L. Hillier, B. Chohan, K. Mandaliya, J. O. Ndinya-Achola, J. Bwayo, and J. Kreiss. 1999. Vaginal lactobacilli, microbial flora, and risk of human immunodeficiency virus type 1 and sexually transmitted disease acquisition. J. Infect. Dis. 180:1863-1868.
26. Mbizvo, E. M., S. E. Msuya, B. Stray-Pedersen, J. Sundby, M. Z. Chirenje, and A. Hussain. 2001. HIV seroprevalence and its associations with the other reproductive tract infections in asymptomatic women in Harare, Zimbabwe. Int. J. STD AIDS 12:524-531.
27. Mostad, S. B., and J. K. Kreiss. 1996. Shedding of HIV-1 in the genital tract. AIDS 10:1305-1315.
28. O'Connor, T. J., D. Kinchington, H. O. Kangro, and D. J. Jeffries. 1995. The activity of candidate virucidal agents, low pH and genital secretions against HIV-1 in vitro. Int. J. STD AIDS 6:267-272.
29. Panther, L. A., L. Tucker, C. Xu, R. E. Tuomala, J. I. Mullins, and D. J. Anderson. 2000. Genital tract human immunodeficiency virus type 1 (HIV-1) shedding and inflammation and HIV-1 env diversity in perinatal HIV-1 transmission. J. Infect. Dis. 181:555-563.
30. Pedraza, M. A., J. del Romero, F. Roldan, S. Garcia, M. C. Ayerbe, A. R. Noriega, and J. Alcami. 1999. Heterosexual transmission of HIV-1 is associated with high plasma viral load levels and a positive viral isolation in the infected partner. J. Acquir. Immune Defic. Syndr. 21:120-125.
31. Poli, G., A. Kinter, J. S. Justement, J. H. Kehrl, P. Bressler, S. Stanley, and A. S. Fauci. 1990. Tumor necrosis factor α functions in an autocrine manner in the induction of human immunodeficiency virus expression. Proc. Natl. Acad. Sci. USA 87:782-785.
32. Poli, G., A. L. Kinter, and A. S. Fauci. 1994. Interleukin 1 induces expression of the human immunodeficiency virus alone and in synergy with interleukin 6 in chronically infected U1 cells: inhibition of inductive effects by the interleukin 1 receptor antagonist. Proc. Natl. Acad. Sci. USA 91:108-112.
33. Poli, G., and A. S. Fauci. 1992. The effect of cytokines and pharmacologic agents on chronic HIV infection. AIDS Res. Hum. Retrovir. 8:191-197.
34. Poli, G., P. Bressler, A. Kinter, E. Duh, W. C. Timmer, A. Rabson, J. S. Justement, S. Stanley, and A. S. Fauci. 1990. Interleukin 6 induces human immunodeficiency virus expression in infected monocytic cells alone and in synergy with tumor necrosis factor a by transcriptional and posttranscriptional mechanisms. J. Exp. Med. 172:151-158.
35. Quinn, T. C., M. J. Wawer, N. Sewankambo, D. Serwadda, C. Li, F. Wabwire-Mangen, M. O. Meehan, T. Lutalo, and R. H. Gray. 2000. Viral load and heterosexual transmission of human immunodeficiency virus type 1. N. Engl. J. Med. 342:921-929.
36. Saracino, A., M. Di Stefano, J. R. Fiore, A. Lepera, D. Raimondi, G. Angarano, and G. Pastore. 2000. Frequent detection of HIV-1 RNA but low rates of HIV-1 isolation in cervicovaginal secretions from infected women. New Microbiol. 23:79-83.
37. Seck, K., N. Samb, S. Tempesta, C. Mulanga-Kabeya, D. Henzel, P. S. Sow, A. Coll-Seck, S. Mboup, I. Ndoye, and E. Delaporte. 2001. Prevalence and risk factors of cervicovaginal HIV shedding among HIV-1 and HIV-2 infected women in Dakar, Senegal. Sex. Transm. Infect. 77:190-193.
38. Sewankambo, N., R. H. Gray, M. J. Wawer, L. Paxton, D. McNaim, F. Wabwire-Mangen, D. Serwadda, C. Li, N. Kiwanuka, S. L. Hillier, L. Rabe, C. A. Gaydos, T. C. Quinn, and J. Konde-Lule. 1997. HIV-1 infection associated with abnormal vaginal flora morphology and bacterial vaginosis. Lancet 350:546-550.
39. Sha, B. E., R. D. D'Amico, A. L. Landay, G. T. Spear, L. S. Massad, R. J. Rydman, N. A. Warner, J. Padnick, L. Ackatz, L. A. Charles, and C. A. Benson. 1997. Evaluation of immunologic markers in cervicovaginal fluid of HIV-infected and uninfected women: implications for the immunologic response to HIV in the female genital tract. J. Acquir. Immune Defic. Syndr. 16:161-168.
40. Spear, G. T., L. al-Harthi, B. Sha, M. N. Saarloos, M. Hayden, L. S. Massad, C. Benson, K. A. Roebuck, N. R. Glick, and A. Landay. 1997. A potent activator of HIV-1 replication is present in the genital tract of a subset of HIV-1-infected and uninfected women. AIDS 11:1319-1326.
41. Taha, T. E., D. R. Hoover, G. A. Dallabetta, N. I. Kumwenda, L. A. Mtimavalye, L. P. Yang, G. N. Liomba, R. L. Broadhead, J. D. Chiphangwi, and P. G. Miotti. 1998. Bacterial vaginosis and disturbances of vaginal flora: association with increased acquisition of HIV. AIDS 12:1699-1706.
42. Turpin, J. A. 2002. Considerations and development of topical microbicides to inhibit the sexual transmission of HIV. Expert Opin. Inv. Drug 11:1077-1097.
43. Vodicka, M. A., W. C. Goh, L. I. Wu, M. E. Rogel, S. R. Bartz, V. L. Schweickart, C. J. Raport, and M. Emerman. 1997. Indicator cell lines for detection of primary strains of human and simian immunodeficiency viruses. Virology 233:193-198.
44. Vogt, M. W., D. J. Witt, D. E. Craven, R. Byington, D. F. Crawford, M. S. Hutchinson, R. T. Schooley, and M. S. Hirsch. 1987. Isolation patterns of the human immunodeficiency virus from cervical secretions during the menstrual cycle of women at risk for the acquired immunodeficiency syndrome. Ann. Intern. Med. 106:380-382.
45. Vogt, M. W., D. J. Witt, D. E. Craven, R. Byington, D. F. Crawford, R. T. Schooley, and M. S. Hirsch. 1986. Isolation of HTLV-III/LAV from cervical secretions of women at high risk for AIDS. Lancet i:525-527.
46. Wofsy, C. B., J. B. Cohen, L. B. Hauer, N. S. Padian, B. A. Michaelis, L. A. Evans, and J. A. Levy. 1986. Isolation of AIDS-associated retrovirus from genital secretions of women with antibodies to the virus. Lancet i:527-529.
47. Wright, T. C., Jr., S. Subbarao, T. V. Ellerbrock, J. L. Lennox, T. Evans-Strickfaden, D. G. Smith, and C. E. Hart. 2001. Human immunodeficiency virus 1 expression in the female genital tract in association with cervical inflammation and ulceration. Am. J. Obstet. Gynecol. 184:279-285.